AAAAAA
Results:
1-8
|
Results: 8
Authors:
Alterman, AI
Gariti, P
Mulvaney, F
Citation: Ai. Alterman et al., Short- and long-term smoking cessation for three levels of intensity of behavioral treatment, PSYCH ADDIC, 15(3), 2001, pp. 261-264
Authors:
Kampman, KM
Volpicelli, JR
Mulvaney, F
Alterman, AI
Cornish, J
Gariti, P
Cnaan, A
Poole, S
Muller, E
Acosta, T
Luce, D
O'Brien, C
Citation: Km. Kampman et al., Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity, DRUG AL DEP, 63(1), 2001, pp. 69-78
Authors:
Staab, JP
Datto, CJ
Weinrieb, RM
Gariti, P
Rynn, M
Evans, DL
Citation: Jp. Staab et al., Detection and diagnosis of psychiatric disorders in primary medical care settings, MED CLIN NA, 85(3), 2001, pp. 579
Authors:
Kampman, KM
Rukstalis, M
Pettinati, H
Muller, E
Acosta, T
Gariti, P
Ehrman, R
O'Brien, CP
Citation: Km. Kampman et al., The combination of phentermine and fenfluramine reduced cocaine withdrawalsymptoms in an open trial, J SUBST ABU, 19(1), 2000, pp. 77-79
Authors:
Gariti, P
Alterman, AI
Mulvaney, FD
Epperson, L
Citation: P. Gariti et al., The relationship between psychopathology and smoking cessation treatment response, DRUG AL DEP, 60(3), 2000, pp. 267-273
Authors:
Gariti, P
Alterman, AI
Barber, W
Bedi, N
Luck, G
Cnaan, A
Citation: P. Gariti et al., Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting, DRUG AL DEP, 54(2), 1999, pp. 111-116
Authors:
Alterman, AI
Gariti, P
Cook, TG
Cnaan, A
Citation: Ai. Alterman et al., Nicodermal patch adherence and its correlates, DRUG AL DEP, 53(2), 1999, pp. 159-165
Authors:
Kampman, KM
Rukstalis, M
Ehrman, R
McGinnis, DE
Gariti, P
Volpicelli, JR
Pettinati, H
O'Brien, CP
Citation: Km. Kampman et al., Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence, ADDICT BEHA, 24(2), 1999, pp. 287-291
Risultati:
1-8
|